Health Care/Hospital
Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology
JINAN, China, Jan. 30, 2024 /PRNewswire/ -- The interim analysis results from the phase III INSPIRE study of iruplinalkib developed by Qilu Pharmaceutical, which focuses on the first-line treatment of locally advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung can...
2024-01-30 16:45
1552
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
* The nomination of novel Kv1.3 inhibitor DPT0218 for the treatment of various immunological diseases including IBD and AD. • DPT0218 is a gut-restricted, highly potent and selective Kv1.3 inhibitor with excellent in vivo efficacy and safety profile in preclinical studies. * This project fur...
2024-01-30 16:32
1855
MGI Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research
The company will offer new and improved solutions for sample pre-treatment, sample preparation and integrated testing, leveraging its innovative technologies and expertise in genetic sequencing and multi-omics. SHENZHEN, China, Jan. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. (referred to as MGI...
2024-01-30 15:55
1929
FRESH PET FOOD PROVEN CRUCIAL FOR LONG-TERM HEALTH AND FINANCIAL SAVINGS, REVEALS INDEPENDENT SMU STUDY
SINGAPORE, Jan. 29, 2024 /PRNewswire/ -- Recently, a new study, utilising PetCubes product, revealed insights into the changing pet food preferences among Singapore pet owners. In a comprehensive independent market study conducted by Singapore Management University (SMU) in 2022[1], a notable shif...
2024-01-30 09:05
1527
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation
SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- SiRNA technology offers distinct advantages over conventional approaches, with the potential to target virtually any gene. This technology has emerged as a great strategy for treating a range of diseases, including cancer, viral infections, and genetic...
2024-01-29 21:30
1487
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.
SHANGHAI and ROSELAND, N.J., Jan. 29, 2024 /PRNewswire/ -- Oricell Therapeutics (Oricell), a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for OriCAR-017 for patients with...
2024-01-29 21:08
1773
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder and Chief Scientific Officer
CRANBURY, N.J., Jan. 29, 2024 /PRNewswire/ -- Crystal Bio, an innovative spinout division of Crystal Pharmatech, is excited to announce Dr.Shiaw-Lin (Billy) Wu as its new co-founder and Chief Scientific Officer (CSO). Dr. Wu brings with him more than three decades of experience in the field of...
2024-01-29 21:00
1126
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders
SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company leading the charge in small activating RNA (saRNA) therapeutics, announces a formal collaboration with University Medical Center Utrecht, affiliated withUtrecht University. This strategic ...
2024-01-29 21:00
1362
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial
SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, today announced the completion of patient enrollment and implant...
2024-01-29 21:00
1600
Angel Yeast's 2024 New Year's Resolutions: Advancing Development through Technological Innovation
SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Angel Yeast
2024-01-29 20:44
2508
deCODE genetics: A sequence variant that increases risk of pregnancy loss
REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and theUSA published a study today in Nature Structural & Molecular Biology titled "Variant in the synaptonemal complex protein SYCE2 associates ...
2024-01-29 18:00
1976
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU
SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced the release of ...
2024-01-29 16:17
1563
Asieris Presents for the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU
SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced the first-time ...
2024-01-29 14:05
1583
COSMAX Established OTC Lab…'Targeting the $2.6 Billion U.S. sun care market'
- Actively responding to its global clients targeting the U.S. sun care market - Strengthening the K-Sunscreen formulations lineup including cushions and sticks - Enhancing its expertise in sun care products through OTC Lab SEONGNAM, South Korea, Jan. 26, 2024 /PRNewswire/ -- COSMAX, a global cos...
2024-01-26 22:00
2509
LOHAS Expo Unveiling the New Trend of Global Healthy and Eco-friendly Lifestyles
HONG KONG, Jan. 26, 2024 /PRNewswire/ -- Revealing the future trend of a wellness lifestyle, the "LOHAS Expo 2024" organized by the Exhibition Group officially opened today. The expo will run from now untilJanuary 28th (Friday to Sunday) at Hall 3FG of the Hong Kong Convention and Exhibition Cent...
2024-01-26 20:58
2519
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF THE CONTACT PERSONS SET OUT BELOW, ONJANUARY 26, 2024, AT 11:20 FINNISH TIME / 10:20 SWEDISH TIME. HELSINKI, ...
2024-01-26 20:08
1937
HKUST President Prof. Nancy IP at "Winter Davos" 2024: Longevity is about Adding Life to Years, Not Just Years to Life
Sharing Insights with Global Leaders on Healthy Aging, Sustainability, Climate Change and AI HONG KONG, Jan. 26, 2024 /PRNewswire/ -- President of the Hong Kong University of Science and Technology (HKUST), Prof. Nancy IP was among the esteemed global leaders and personalities attending the 2024...
2024-01-26 16:18
2865
FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System
SEOUL, South Korea, Dec. 12, 2022 /PRNewswire/ -- RF Medical Co., Ltd. is a
premier Korean-based medical company serving the healthcare industry for almost
two decades. Recently, FDA cleared RF Medical's patented MYGEN™ M-3004
generator and MYOBLATE™ radiofrequency ablation system.
2024-01-26 15:26
1010
Endomondo.com is Back Online - As a Professional Fitness Guidance Website
SAN JOSE, Calif, Jan. 25, 2024 /PRNewswire/ -- Endomondo.com, a fitness and
wellness industry pioneer, is excited to announcea significant transformation
as it evolves into a leading professional fitness guidance website
2024-01-26 11:39
1691
AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site
* US$223 million expansion will add biologics capacity to AbbVie manufacturing network * Singapore manufacturing site to grow to more than 500 employees following expansion * Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 /PRNews...
2024-01-26 08:30
5956
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 274 media titles]
2024-11-29 20:33
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
13780
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9866
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8334
